Like it is: Dr. Margaret Flowers talks with Amy Goodman after another single-payer lockout, from the WH Healthcare Summit
Amy Goodman's coverage includes talking with Trudy Lieberman of Columbia Journalism Review, who has paid careful attention to the issues.
Lieberman closes her portion of the health care discussion segment with the topic on which President Obama chose to conclude the White House Healthcare Summit, yesterday.
It's what I think of as the morality versus profits paradox that is concerned with the unwillingness of the world's richest nation to secure for its citizens the most basic assurances provided the constituencies of the rest of the civilized world.
Trudy Lieberman: ...But I think we really still have no agreement on whether everyone in this country, every citizen, should have healthcare and the ticket to buy it. And I think the President was getting to that point at the very end, when he admitted, quite candidly, he does not know whether we can bridge the gap. And the gap that he identified was how are we going to cover the 30 million people that the government wants to cover and deal with getting everyone into a risk pool, dealing with the pre-existing conditions issue, which keeps people out of this, because in a private insurance market you really—insurance companies can’t really choose people who are sick, or they will go out of business eventually. So that is really the question that has not been resolved.
Of course, it is that paradoxical need which single-payer advocates suggest is answered with the sorts of "Medicare-For-All"-based solutions they have been striving to tell our lawmakers about.
Or, at least, they would testify to that effect if the single-payer option experts such as of Mad-As-Hell Doctors were ever provided the same audience and forums granted to other 'stakeholders', an audience of American decision-makers.
AMY GOODMAN: ...Single payer was not a part of yesterday’s discussion. No advocate was there—Dennis Kucinich, not Physicians for a National Health Program. Your group asked to be represented, Dr. Flowers?
DR. MARGARET FLOWERS: We did, because the President had stated that health experts should be involved in this process. And so, we wanted to offer our services as people that do research in this area. And indeed, they quoted several of our studies during the summit.
AMY GOODMAN: What happened? Why wasn’t anyone represented?
DR. MARGARET FLOWERS: Well, you know, this has been a series of—throughout the entire health process, that we’ve been excluded from this discussion. I think it’s pretty basic. It hearkens back to the special interests that have been involved in this process, you know, and we—it’s really interesting to watch this debate, because so many of the areas that the President and Congress are talking about—cost controls, increasing coverage, excluding pre-existing conditions—all of these would be met through a national Medicare-for-All system. But—so we win, you know, on the policy. But there is such a heavy influence from the insurance and pharmaceutical companies that they, I guess, felt threatened by the presence of the single-payer advocates....
With that excerpt in mind, I'll leave you to consider the segment as it follows, in whole.
For the transcript, go to DemocracyNow!